DCGI India launches investigation into 4 cough syrups after WHO warns on death of 66 children in Gambia Ayushi Sikarwar October 6, 2022
DCGI Corbevax COVID-19 vaccine gets DCGI’s nod for children aged 5-12 Ayushi Sikarwar October 6, 2022
DCGI DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12 Ayushi Sikarwar October 6, 2022
DCGI DCGI gives emergency use authorisation to Covaxin for 6-12 age group Ayushi Sikarwar October 6, 2022
DCGI DCGI gives final approval to COVID-19 vaccine Corbevax for 12-18 year olds Ayushi Sikarwar October 6, 2022
DCGI 84-yr-old Haryana man, first in India to get antibody cocktail against Covid-19 mutant Ayushi Sikarwar October 6, 2022
DCGI Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt Ayushi Sikarwar October 6, 2022
DCGI Covid-19 Vaccines are 110 % safe, says Drug Controller General of India Ayushi Sikarwar October 6, 2022
DCGI Pfizer India seeks emergency use authorisation from DCGI for its COVID-19 vaccine in the country Ayushi Sikarwar October 6, 2022
